Table 1.
Characteristic | Participants with spirometry (n = 55) |
Participants with spirometry and oscillometry (n = 64) |
---|---|---|
Sex (male) | 69% | 67% |
Age (SD) | 43.9 (11.0) | 44.0 (11.5) |
BMI (SD) | 25.9 (6.8) | 25.8 (6.9) |
Education | ||
College or university completed | 6% | 7% |
Some college or university | 27% | 31% |
High school graduate/GED | 28% | 27% |
Elementary/ grade school or some high school | 36% | 31% |
None | 1.5% | 2% |
NA | 1.5% | 2% |
Ethnicity | ||
Caucasian | 78% | 73% |
Aboriginal (Metis, Inuit, First Nation) | 19% | 24% |
Other | 3% | 3% |
Monthly income | ||
$200–2999 | 11% | 5% |
$1000–1999 | 43% | 44% |
$500–599 | 33% | 36% |
< $499 | 13% | 15% |
NA | 0% | 0% |
Number of cigarettes/day | ||
< 15 | 53.8% | 38% |
15–25 | 34.6% | 35% |
26–35 | 9% | 13% |
36–40 | 2.6% | 5% |
N/A | 0% | 9% |
Total years tobacco smoking | ||
< 10 | 31.3% | 18% |
10–20 | 11.3% | 13% |
21–30 | 28.7% | 26% |
31–40 | 18.7% | 25% |
41–50 | 7.5% | 11% |
51–60 | 2.5% | 4% |
N/A | 0% | 4% |
Food insecurity | ||
Always (100% of the time) | 18% | 18% |
Most of the time (75–99%) | 10% | 9% |
Usually (50–75% of the time) | 12% | 13% |
Sometimes (25–50% of the time) | 25% | 29% |
Occasionally (< 25% of the time) | 15% | 13% |
Never | 18% | 16% |
NA | 2% | 2% |
Self-reported lung disease* | 21.9% | 23.6% |
Can-COLD | ||
Cough (without cold) | 64% | 62% |
< 2 years | 8% | 9% |
2–5 years | 13% | 13% |
< 5 years | 31% | 29% |
Phlegm (without cold) | 70% | 65% |
< 2 years | 17% | 16% |
2–5 years | 9% | 7% |
< 5 years | 20% | 20% |
Wheezing/whistling | 72% | 67% |
Wheezing with cold | 33% | 33% |
Shortness of Breath | 39% | 35% |
Unable to Walk | 36% | 35% |
CAT Score (mean/SD) | 25.78 (8.45) | 17.16 (8.11) |
Cough | 4.03 (1.36) | 3.00 (1.39) |
Phlegm | 3.92 (1.46) | 2.95 (1.52) |
Chest | 3.06 (1.62) | 1.98 (1.57) |
Walk | 3.34 (1.85) | 2.25 (1.86) |
Activities | 2.55 (1.60) | 1.44 (1.50) |
Confident | 2.47 (1.83) | 1.40 (1.74) |
Sleep | 3.25 (1.88) | 2.07 (1.76) |
Energy | 3.21 (1.61) | 2.11 (1.59) |
*Asthma, Chronic Obstructive Lung Disease, Emphysema and/or Lung Cancer